Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes

International Journal of Breast Cancer - Tập 2013 - Trang 1-15 - 2013
Denise A. Yardley1
1Breast Cancer Research, Sarah Cannon Research Institute, 250 25th Avenue North, Suite 110, Nashville, TN 37203, USA

Tóm tắt

Resistance to cancer chemotherapy is a common phenomenon especially in metastatic breast cancer (MBC), a setting in which patients typically have had exposure to multiple lines of prior therapy. The subsequent development of drug resistance can result in rapid disease progression during or shortly after completion of treatment. Moreover, cross-class multidrug resistance limits patient treatment choices, particularly in a setting where treatments options are few. One attempt to minimize the impact of drug resistance has been the concurrent use of two or more chemotherapy agents with unrelated mechanisms of action and differing modes of drug resistance, with the intent of blocking the development of multiple intracellular escape pathways essential for tumor survival. Within the past decade, an array of mechanistically diverse agents has augmented the list of combination regimens that may be both synergistic and efficacious in pretreated MBC. The aim of this paper is to review mechanisms of resistance to common chemotherapy agents and to consider current combination treatment options for heavily pretreated and/or drug-resistant patients with MBC.

Từ khóa


Tài liệu tham khảo

10.1200/JCO.2005.05.2308

10.1634/theoncologist.12-4-375

2000, Nature, 406, 747, 10.1038/35021093

2001, Proceedings of the National Academy of Sciences of the United States of America, 98, 10869, 10.1073/pnas.191367098

2003, Proceedings of the National Academy of Sciences of the United States of America, 100, 8418, 10.1073/pnas.0932692100

2008, Histopathology, 52, 82, 10.1111/j.1365-2559.2007.02897.x

10.1177/1947601910383418

10.3816/CBC.2009.n.005

10.1200/JCO.2009.24.9284

10.1093/annonc/mdr304

2011, Modern Pathology, 24, 201, 10.1038/modpathol.2010.191

10.1677/erc.1.01005

10.1186/bcr1612

10.3816/CBC.2010.s.015

2010, The Oncologist, 15, 49

2001, Journal of Clinical Oncology, 19, 1707, 10.1200/JCO.2001.19.6.1707

10.1200/JCO.2002.11.005

10.1200/JCO.2003.04.040

10.1200/JCO.2003.08.013

10.1200/JCO.2005.01.1817

10.1007/s10549-008-0232-x

1999, Journal of Clinical Oncology, 17, 2341, 10.1200/JCO.1999.17.8.2341

10.1056/NEJM200103153441101

10.1056/NEJMoa072113

2008, Journal of Clinical Oncology, 26, 43s

10.1200/JCO.2010.28.0982

2005, Journal of Pathology, 205, 275, 10.1002/path.1706

10.1200/JCO.2003.11.071

10.3816/CBC.2007.n.048

10.1002/cncr.11859

2002, Nature Reviews Cancer, 2, 48, 10.1038/nrc706

10.1007/s10549-008-0005-6

2009, Pharmacotherapy, 29, 954, 10.1592/phco.29.8.954

1997, Journal of the National Cancer Institute, 89, 917, 10.1093/jnci/89.13.917

10.1074/jbc.M414477200

10.1093/annonc/mdi902

2009, Journal of Clinical Oncology, 27, 167s, 10.1200/JCO.2009.24.0929

2007, Clinical Cancer Research, 13, 2849, 10.1158/1078-0432.CCR-06-3040

2005, Proceedings of the National Academy of Sciences of the United States of America, 102, 8315, 10.1073/pnas.0408974102

10.1007/s00280-008-0877-5

10.1200/JCO.2007.14.2646

10.1158/1535-7163.MCT-08-0986

10.1007/s10549-011-1687-8

10.1016/j.drup.2004.06.005

10.1038/sj.onc.1208955

1993, Proceedings of the National Academy of Sciences of the United States of America, 90, 2960, 10.1073/pnas.90.7.2960

10.1158/1535-7163.MCT-06-0663

10.1093/annonc/mdl475

10.1084/jem.20091846

10.1038/nrc2713

10.1634/theoncologist.2009-0142

10.1158/1078-0432.CCR-09-1764

2011, Breast Cancer Research and Treatment, 130, 377, 10.1007/s10549-010-1312-2

2006, Clinical Cancer Research, 12, 424, 10.1158/1078-0432.CCR-05-1807

2011, Cell Cycle, 10, 3003, 10.4161/cc.10.17.17119

2000, Journal of Clinical Oncology, 18, 1124, 10.1200/JCO.2000.18.5.1124

10.1002/cncr.21227

2011, BMC Cancer, 11, article 420

2011, Journal of Clinical Oncology, 29

2012, New England Journal of Medicine, 366, 520, 10.1056/NEJMoa1109653

2012, Journal of Clinical Oncology, 30, 2718, 10.1200/JCO.2011.39.0708

2012, Bulletin of Mathematical Biology, 74, 434, 10.1007/s11538-011-9693-x

1996, Journal of Clinical Oncology, 14, 2197, 10.1200/JCO.1996.14.8.2197

2002, Journal of Clinical Oncology, 20, 2812, 10.1200/JCO.2002.09.002

2004, Clinical Breast Cancer, 5, 273, 10.3816/CBC.2004.n.030

2004, British Journal of Cancer, 90, 1740, 10.1038/sj.bjc.6601784

10.3816/CBC.2007.n.003

10.1200/JCO.2007.11.9362

10.1200/JCO.2007.15.8485

2007, Journal of Clinical Oncology, 25, 5210, 10.1200/JCO.2007.12.6557

10.1016/S1470-2045(07)70041-4

10.1200/JCO.2005.05.098

10.1007/s10549-007-9885-0

2006, New England Journal of Medicine, 355, 2733, 10.1056/NEJMoa064320

2008, Journal of Clinical Oncology, 26, 44s, 10.1200/JCO.2007.11.3787

2009, Cancer Research, 69

10.1200/JCO.2008.21.4437

1998, Journal of Clinical Oncology, 16, 3439, 10.1200/JCO.1998.16.10.3439

10.1093/jnci/djp235

1998, Clinical Cancer Research, 4, 1013

2007, Journal of Clinical Oncology, 25

10.1093/annonc/mdj976

10.1023/A:1008315723253

2000, Cancer Investigation, 18, 503, 10.3109/07357900009012188

10.1093/annonc/mdn661

10.1007/s00280-008-0727-5

2001, Clinical Cancer Research, 7, 1429

1998, Proceedings of the National Academy of Sciences of the United States of America, 95, 15798, 10.1073/pnas.95.26.15798

2006, Proceedings of the American Association For Cancer Research

10.1177/1758834010386402

2008, Breast Cancer Symposium Proceedings, 178

10.1007/s10549-009-0658-9

2010, Journal of Clinical Oncology, 28

10.1200/JCO.2010.30.8213

2004, Clinical Breast Cancer, 4, S113, 10.3816/CBC.2004.s.004

10.3816/CBC.2008.n.019

10.3816/CBC.2008.n.051

2011, New England Journal of Medicine, 364, 205, 10.1056/NEJMoa1011418

2011, Journal of Clinical Oncology, 29

1991, Journal of Biological Chemistry, 266, 15882, 10.1016/S0021-9258(18)98491-7

2001, Cancer Research, 61, 1013

2007, AACR Meeting Abstracts

10.1200/JCO.2008.17.7618

10.1200/JCO.2009.25.8467

2010, Journal of Clinical Oncology, 28

10.1016/S0140-6736(11)60070-6

2005, New England Journal of Medicine, 353, 1673, 10.1056/NEJMoa052122

10.1016/S0140-6736(07)60028-2

2004, Journal of the National Cancer Institute, 96, 759, 10.1093/jnci/djh133

10.1200/JCO.2004.08.065

10.1200/JCO.2005.04.1764

10.1200/JCO.2006.09.6826

10.1007/s00280-008-0882-8

2008, Cancer Chemotherapy and Pharmacology, 62, 903, 10.1007/s00280-008-0682-1

2009, Cancer Research, 69

10.3816/CBC.2009.n.004

2011, Cancer Research, 71

2010, Journal of Clinical Oncology, 28

2011, Journal of Clinical Oncology, 29

2011, Journal of Clinical Oncology, 29, 4286, 10.1200/JCO.2010.34.1255

2012, Journal of Clinical Oncology, 30

2007, Journal of Clinical Oncology, 25, 35s

2009, Cancer Research, 69

2008, Journal of Clinical Oncology, 26, 51s

10.1200/JCO.2009.24.2024

2012, New England Journal of Medicine, 366, 109, 10.1056/NEJMoa1113216

Thông tin
Thông tin xuất bản

International Journal of Breast Cancer

Tập 2013

1-15

Thông tin tác giả